GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenicin Inc (OTCPK:RGIN) » Definitions » Float Percentage Of Total Shares Outstanding

Regenicin (Regenicin) Float Percentage Of Total Shares Outstanding : 88.36% (As of May. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Regenicin Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Regenicin's float shares is 135.61 Mil. Regenicin's total shares outstanding is 153.48 Mil. Regenicin's float percentage of total shares outstanding is 88.36%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Regenicin's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Regenicin's Institutional Ownership is 0.00%.

Regenicin Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Regenicin's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=135.61/153.48
=88.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenicin (Regenicin) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenicin Inc (OTCPK:RGIN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
NOVNQ TMBRQ RGRX PCNT NMTRQ ONCSQ QBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY XBRU:ARGX OCSE:GMAB SZSE:300122
Traded in Other Exchanges
N/A
Address
10 High Court, Little Falls, NJ, USA, 07424
Website
https://www.regenicin.com
Regenicin Inc is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Its skin substitute product candidate comprises of NovaDerm. NovaDerm is a multi-layered tissue-engineered living skin prepared by utilizing autologous (patient's own) skin cells. It is a graftable cultured epithelium skin substitute containing both epidermal and dermal components with a collagen base. The technology has been clinically tested in Hundreds of pediatric, catastrophic burn patients.

Regenicin (Regenicin) Headlines

No Headlines